NDC Active Ingredient Letermovir

Active Ingredient Information

What is the usage for Letermovir?

This medication is used to prevent disease caused by a virus called cytomegalovirus (CMV) in people who have received a bone marrow transplant. CMV disease can lead to serious infections in the body, including an infection in the eye, called CMV retinitis, that can cause blindness. Letermovir is an anti-viral drug. It works by stopping the growth of the virus.

How many products in the NDC database contain Letermovir?

The NDC database has 7 products with the active ingredient Letermovir. The following table lists all the products that have this active ingredient.

NDC Products with Letermovir

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0006-3075Proprietary Name: Prevymis LetermovirTablet, Film CoatedOralMerck Sharp & Dohme LlcACTIVE
0006-3076Proprietary Name: Prevymis LetermovirTablet, Film CoatedOralMerck Sharp & Dohme LlcACTIVE
0006-5003Proprietary Name: Prevymis LetermovirInjection, SolutionIntravenousMerck Sharp & Dohme LlcACTIVE
0006-5004Proprietary Name: Prevymis LetermovirInjection, SolutionIntravenousMerck Sharp & Dohme LlcACTIVE
50473-0126Proprietary Name: LetermovirTablet, Film CoatedMsd International GmbhACTIVE
50473-0127Proprietary Name: LetermovirTablet, Film CoatedMsd International GmbhACTIVE
69497-0128Proprietary Name: LetermovirInjection, SolutionMsd Ireland (carlow)ACTIVE
<